Designing a Trial of Bilateral Cochlear Implantation in Adults

Last updated: May 21, 2019
Sponsor: Nottingham University Hospitals NHS Trust
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hearing Impairment

Deafness

Hearing Loss

Treatment

N/A

Clinical Study ID

NCT03287700
16IH004
PB-PG-0815-20039
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

In the UK, cochlear implantation is the standard treatment for adults with 'severe-to-profound' deafness. This level of deafness means that without a cochlear implant they have difficulty understanding what people are saying even when they wear hearing aids. The NHS provides a cochlear implant for one ear even though these adults are deaf in both ears. Two cochlear implants could help them understand speech in noisy environments, know where to look to see who is talking, and avoid hazards outdoors.

The decision about who can receive cochlear implants and how many they can receive is based on guidance from the National Institute for Health and Care Excellence (NICE). NICE agreed that providing two cochlear implants can provide additional benefits over providing just one implant. However, they decided that there is not enough evidence to show that these additional benefits are worth the additional cost of providing the second implant. NICE recommended that a clinical trial should be conducted to gather this evidence.

This study will consult with patients to explore whether the trial would be acceptable to future implant recipients. The study will also work with clinicians to design a trial comparing bilateral and unilateral implantation in adults. These clinicians will also be surveyed to assess the acceptability of the trial. A group of clinicians that span the range of professions involved in delivering the care pathway will be invited to attend a trial design workshop to establish a consensus on acceptable trial design elements from a clinical perspective. Representatives from cochlear implant manufacturers will be consulted to determine possible strategies for securing industry support for a future trial. Those who run cochlear implantation services will be engaged in a working group to gather information on the current care pathway to inform future assessments of whether bilateral implantation could be cost-effective.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All participants will be 18 years or older at the time consent is obtained.

  • Patients who participate in the focus groups and/or online survey must have received acochlear implant on the NHS in the UK or must be currently being assessed foreligibility to receive a unilateral cochlear implantation by an NHS service provider.

  • Clinicians who participate in the trial design workshop and/or the online survey mustbe employed by a provider of NHS cochlear implantation services in the UK and be aclinically-trained professional who delivers one or more aspects of the cochlearimplantation care pathway.

  • Representatives from manufacturers who attend the industry forum must be employed by amanufacturer of cochlear implants and hold a role that includes responsibility fordeveloping, co-ordinating, or managing research activity sponsored and/or funded bythe manufacturer.

  • Clinicians who participate in the care pathway working group must be employed by aprovider of NHS cochlear implantation services in the UK and have a head of service orco-ordinator role in their cochlear implant service or have been delegatedresponsibility to contribute on behalf of a head of service / co-ordinator.

Exclusion

Exclusion Criteria:

• None.

Study Design

Total Participants: 86
Study Start date:
June 14, 2017
Estimated Completion Date:
August 02, 2019

Study Description

The study design comprises focus groups, online surveys, a trial design workshop, a manufacturer's forum, and a care pathway working group.

Focus groups Two focus groups will be conducted to explore issues around the acceptability of the two-arm trial recommended by NICE. The recruitment strategy will target both individuals who have been referred for a cochlear implant but have yet to receive one and also existing users of a cochlear implant. The focus groups will explore issues such as acceptance of randomisation, how to minimise the burden associated with participating, potential barriers to participation, and how to communicate the purpose of the trial clearly and effectively to prospective participants.

Online surveys Online surveys, informed by the focus groups, will be used to capture the views of the wider population of patients and of clinicians who deliver cochlear implant services on the acceptability of the trial. Both surveys will use open and closed questions. The surveys will explore the acceptability of the trial.

Trial design workshop Following the focus groups and surveys, an all-day workshop will be conducted with clinicians who deliver the current care pathway for cochlear implantation. The workshop will comprise a focus group and a trial design session. The focus group will seek to identify pertinent issues with the trial design from the perspective of the clinicians. The group will then be tasked with reaching a consensus on a trial design that would be both acceptable to them and which is feasible to conduct.

Manufacturer's forum Major manufacturers who supply cochlear implants to the NHS will be invited to attend a manufacturer's forum near the end of the study. They will be presented with the results of the acceptability assessment. The forum will explore whether the manufacturers would consider supporting the trial.

Care pathway working group A working group of cochlear implant service coordinators will be established to examine the existing decision analytic model commissioned by NICE and to identify the aspects of the model that require updating. The group will identify those parameters for which relevant information may be available from their own service records and will be tasked to reach a consensus on individual values for each parameter that would generally represent service provision across the providers. The group will also define plausible ranges for each parameter which could be used in future sensitivity analyses of any decision-analytic model.

Connect with a study center

  • Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool

    Liverpool, L12 2AP
    United Kingdom

    Active - Recruiting

+−

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.